LakeShore Financial Statements From 2010 to 2025

LSBPW Stock   0.04  0.00  0.000002%   
LakeShore Biopharma financial statements provide useful quarterly and yearly information to potential LakeShore Biopharma Co, investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on LakeShore Biopharma financial statements helps investors assess LakeShore Biopharma's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting LakeShore Biopharma's valuation are summarized below:
Gross Profit
386.1 M
Profit Margin
(0.76)
Revenue
573.4 M
Quarterly Revenue Growth
0.277
Revenue Per Share
53.629
There are over one hundred nineteen available fundamental ratios for LakeShore Biopharma, which can be analyzed over time and compared to other ratios. All traders should should check LakeShore Biopharma's last-minute fundamental trends against the trends from 2010 to 2025 to make sure the company is sustainable.

LakeShore Biopharma Total Revenue

555.66 Million

Check LakeShore Biopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LakeShore Biopharma's main balance sheet or income statement drivers, such as Depreciation And Amortization of 37.9 M, Interest Expense of 29.6 M or Selling General Administrative of 130.7 M, as well as many indicators such as Price To Sales Ratio of 10.68, Dividend Yield of 0.0 or PTB Ratio of 10.46. LakeShore financial statements analysis is a perfect complement when working with LakeShore Biopharma Valuation or Volatility modules.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

LakeShore Biopharma Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets944.3 M1.7 B382.4 M
Slightly volatile
Short and Long Term Debt Total358.5 M488.1 M134.4 M
Slightly volatile
Total Current Liabilities968.7 M922.6 M209.6 M
Slightly volatile
Total Stockholder Equity410.9 M673 M161.2 M
Slightly volatile
Property Plant And Equipment Net517.5 M552.7 M342.9 M
Slightly volatile
Current Deferred Revenue1.7 M1.8 M2.1 M
Slightly volatile
Accounts Payable53.7 M77.9 M30.7 M
Slightly volatile
Cash201.6 M221.7 M333.5 M
Slightly volatile
Non Current Assets Total410.8 M701.3 M162.9 M
Slightly volatile
Long Term Debt178.1 M113.8 M59.4 M
Slightly volatile
Cash And Short Term Investments201.6 M221.7 M333.5 M
Slightly volatile
Net Receivables403.4 M514.2 M304.1 M
Slightly volatile
Common Stock Shares Outstanding66.7 M123 M45 M
Slightly volatile
Liabilities And Stockholders Equity944.3 M1.7 B382.4 M
Slightly volatile
Non Current Liabilities Total107.4 M113 M958.7 M
Slightly volatile
Capital Lease Obligations10.1 M6.2 M15 M
Slightly volatile
Inventory175.1 M233.9 M116.3 M
Slightly volatile
Other Current Assets10.1 M5.6 M12.4 M
Slightly volatile
Total Liabilities1.1 B1.1 B258 M
Slightly volatile
Property Plant And Equipment Gross755.9 M915.7 M536 M
Slightly volatile
Total Current Assets735.2 MB736.2 M
Pretty Stable
Capital Stock31.5 K30 K12.2 K
Slightly volatile
Net Working Capital86.3 M90.8 M325.9 M
Slightly volatile
Short Term Debt390.9 M372.3 M90.2 M
Slightly volatile
Intangible Assets62.8 M64.1 M79.9 M
Slightly volatile
Common Stock31.5 K30 K6.7 K
Slightly volatile
Short and Long Term Debt228.8 M366.3 M153 M
Slightly volatile

LakeShore Biopharma Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization37.9 M48.5 M31.5 M
Slightly volatile
Interest Expense29.6 M51 M30.3 M
Pretty Stable
Selling General Administrative130.7 M169.8 M135.3 M
Pretty Stable
Selling And Marketing Expenses211 M322.5 M124.7 M
Slightly volatile
Total Revenue555.7 M659.4 M362.9 M
Slightly volatile
Gross Profit432.5 M524.1 M281.4 M
Slightly volatile
Other Operating Expenses604.9 M1.2 B485.6 M
Slightly volatile
Research Development255 M348.2 M154.6 M
Slightly volatile
Cost Of Revenue123.1 M135.3 M81.4 M
Slightly volatile
Total Operating Expenses1.1 BB449.4 M
Slightly volatile
Reconciled Depreciation37.9 M48.5 M31.5 M
Slightly volatile

LakeShore Biopharma Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation8.4 M8.8 M55.2 M
Slightly volatile
Begin Period Cash Flow284.3 M425.9 M110.3 M
Slightly volatile
Depreciation37.9 M48.5 M31.5 M
Slightly volatile
Capital Expenditures37.8 M39.8 M102 M
Pretty Stable
Total Cash From Financing Activities292.7 M184.7 M583.3 M
Slightly volatile
End Period Cash Flow201.7 M221.9 M333.5 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio10.6811.2452.7839
Slightly volatile
PTB Ratio10.4611.01574.7 K
Slightly volatile
Days Sales Outstanding304327329
Slightly volatile
Book Value Per Share4.24.931.8841
Slightly volatile
Average Payables51.9 M66.7 M57.2 M
Slightly volatile
Stock Based Compensation To Revenue0.01870.01960.2101
Slightly volatile
Capex To Depreciation1.151.213.4939
Slightly volatile
PB Ratio10.4611.01574.7 K
Slightly volatile
EV To Sales11.0211.651.8615
Slightly volatile
Inventory Turnover0.780.670.726
Pretty Stable
Days Of Inventory On Hand418568504
Pretty Stable
Payables Turnover3.052.03.2842
Slightly volatile
Sales General And Administrative To Revenue0.310.30.4465
Slightly volatile
Average Inventory140.8 M158.3 M172.6 M
Slightly volatile
Research And Ddevelopement To Revenue0.350.480.3926
Slightly volatile
Capex To Revenue0.08430.08870.3385
Slightly volatile
Cash Per Share2.522.6510.1048
Slightly volatile
Days Payables Outstanding120189119
Slightly volatile
Income Quality1.20.781.1988
Slightly volatile
Intangibles To Total Assets0.05140.0542630
Slightly volatile
Current Ratio1.231.297.2 K
Slightly volatile
Receivables Turnover1.091.151.1269
Slightly volatile
Shareholders Equity Per Share4.24.931.8841
Slightly volatile
Debt To Equity0.750.650.4685
Slightly volatile
Capex Per Share0.450.483.2715
Slightly volatile
Average Receivables308.6 M347.2 M378.6 M
Slightly volatile
Revenue Per Share11.076.179.179
Very volatile
Interest Debt Per Share5.053.952.7862
Slightly volatile
Debt To Assets0.310.320.231
Slightly volatile
Operating Cycle639824823
Slightly volatile
Price Book Value Ratio10.4611.01574.7 K
Slightly volatile
Days Of Payables Outstanding120189119
Slightly volatile
Ebt Per Ebit1.221.171.2926
Slightly volatile
Company Equity Multiplier2.842.973.6823
Slightly volatile
Long Term Debt To Capitalization0.160.170.7586
Slightly volatile
Total Debt To Capitalization0.340.380.2696
Slightly volatile
Debt Equity Ratio0.750.650.4685
Slightly volatile
Net Income Per E B T1.121.11.0806
Slightly volatile
Cash Ratio0.340.353.8 K
Slightly volatile
Cash Conversion Cycle715811727
Slightly volatile
Days Of Inventory Outstanding418568504
Pretty Stable
Days Of Sales Outstanding304327329
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.261.3231.8248
Pretty Stable
Price To Book Ratio10.4611.01574.7 K
Slightly volatile
Fixed Asset Turnover0.861.071.0217
Very volatile
Debt Ratio0.310.320.231
Slightly volatile
Price Sales Ratio10.6811.2452.7839
Slightly volatile
Asset Turnover0.410.441.9 K
Slightly volatile
Gross Profit Margin0.620.720.7578
Slightly volatile
Price Fair Value10.4611.01574.7 K
Slightly volatile

LakeShore Biopharma Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap7.8 B6.4 B8.1 B
Slightly volatile
Enterprise Value7.9 B6.7 B8.3 B
Slightly volatile

LakeShore Fundamental Market Drivers

Cash And Short Term Investments246.4 M

About LakeShore Biopharma Financial Statements

LakeShore Biopharma investors use historical fundamental indicators, such as LakeShore Biopharma's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in LakeShore Biopharma. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue1.8 M1.7 M
Total Revenue659.4 M555.7 M
Cost Of Revenue135.3 M123.1 M
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 0.30  0.31 
Research And Ddevelopement To Revenue 0.48  0.35 
Capex To Revenue 0.09  0.08 
Revenue Per Share 6.17  11.07 
Ebit Per Revenue(0.89)(0.85)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for LakeShore Stock Analysis

When running LakeShore Biopharma's price analysis, check to measure LakeShore Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LakeShore Biopharma is operating at the current time. Most of LakeShore Biopharma's value examination focuses on studying past and present price action to predict the probability of LakeShore Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LakeShore Biopharma's price. Additionally, you may evaluate how the addition of LakeShore Biopharma to your portfolios can decrease your overall portfolio volatility.